Cargando…

Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review

Asymptomatic hyperuricemia is increasing in prevalence. There is a growing body of literature suggesting that uric acid has deleterious effects on vascular health and renal histological integrity. Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Maria Erika G., Bargman, Joanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512147/
https://www.ncbi.nlm.nih.gov/pubmed/28748121
http://dx.doi.org/10.1016/j.jare.2017.04.006
_version_ 1783250450094489600
author Ramirez, Maria Erika G.
Bargman, Joanne M.
author_facet Ramirez, Maria Erika G.
Bargman, Joanne M.
author_sort Ramirez, Maria Erika G.
collection PubMed
description Asymptomatic hyperuricemia is increasing in prevalence. There is a growing body of literature suggesting that uric acid has deleterious effects on vascular health and renal histological integrity. Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a slowing in the rate of renal deterioration in those with chronic kidney disease. Given that there is little available in the general armamentarium to slow the rate of kidney deterioration, strong consideration could be given to the administration of agents or lifestyle changes that decrease uric acid production in hyperuricemic patients with deteriorating kidney function.
format Online
Article
Text
id pubmed-5512147
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-55121472017-07-26 Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review Ramirez, Maria Erika G. Bargman, Joanne M. J Adv Res Review Asymptomatic hyperuricemia is increasing in prevalence. There is a growing body of literature suggesting that uric acid has deleterious effects on vascular health and renal histological integrity. Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a slowing in the rate of renal deterioration in those with chronic kidney disease. Given that there is little available in the general armamentarium to slow the rate of kidney deterioration, strong consideration could be given to the administration of agents or lifestyle changes that decrease uric acid production in hyperuricemic patients with deteriorating kidney function. Elsevier 2017-09 2017-05-02 /pmc/articles/PMC5512147/ /pubmed/28748121 http://dx.doi.org/10.1016/j.jare.2017.04.006 Text en © 2017 Production and hosting by Elsevier B.V. on behalf of Cairo University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Ramirez, Maria Erika G.
Bargman, Joanne M.
Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
title Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
title_full Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
title_fullStr Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
title_full_unstemmed Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
title_short Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy – A review
title_sort treatment of asymptomatic hyperuricemia in chronic kidney disease: a new target in an old enemy – a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512147/
https://www.ncbi.nlm.nih.gov/pubmed/28748121
http://dx.doi.org/10.1016/j.jare.2017.04.006
work_keys_str_mv AT ramirezmariaerikag treatmentofasymptomatichyperuricemiainchronickidneydiseaseanewtargetinanoldenemyareview
AT bargmanjoannem treatmentofasymptomatichyperuricemiainchronickidneydiseaseanewtargetinanoldenemyareview